![SciELO - Brasil - Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement SciELO - Brasil - Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement](https://minio.scielo.br/documentstore/1414-431X/fhYBzgrmKVZwtbhFQhRwPGK/52a09e0f6550611584cde534e9c5c3e809f3031a.jpg)
SciELO - Brasil - Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
![Diagnostic value of anti-cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjögren's syndrome | Annals of the Rheumatic Diseases Diagnostic value of anti-cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjögren's syndrome | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/64/1/160/F1.large.jpg)
Diagnostic value of anti-cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjögren's syndrome | Annals of the Rheumatic Diseases
![Comparison of Anti-CCP Peptide with Rheumatoid Factor and its Isotypes for Early Differential Diagnosis and Prognosis of Rheumatoid Arthritis - SciAlert Responsive Version Comparison of Anti-CCP Peptide with Rheumatoid Factor and its Isotypes for Early Differential Diagnosis and Prognosis of Rheumatoid Arthritis - SciAlert Responsive Version](https://docsdrive.com/images/ansinet/jms/2010/tab3-2k10-19-24.gif)
Comparison of Anti-CCP Peptide with Rheumatoid Factor and its Isotypes for Early Differential Diagnosis and Prognosis of Rheumatoid Arthritis - SciAlert Responsive Version
A modified quick PETIA for detecting anti-CCP antibodies in human serum - Analytical Methods (RSC Publishing)
![PDF) Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF PDF) Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF](https://www.researchgate.net/profile/Ines-Silveira-3/publication/6412298/figure/tbl2/AS:601667330383879@1520460078376/Disease-probability-after-combination-of-RF-and-anti-CCP-antibodies-and-LRs_Q320.jpg)
PDF) Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF
![Relationship between Anti-CCP Antibodies and Oxidant and Anti-Oxidant Activity in Patients with Rheumatoid Arthritis Relationship between Anti-CCP Antibodies and Oxidant and Anti-Oxidant Activity in Patients with Rheumatoid Arthritis](https://www.medsci.org/v08/p0139/ijmsv08p0139g04.jpg)
Relationship between Anti-CCP Antibodies and Oxidant and Anti-Oxidant Activity in Patients with Rheumatoid Arthritis
![Anticyclic Citrullinated Peptide Antibodies 3.1 and Anti-CCP-IgA Are Associated with Increasing Age in Individuals Without Rheumatoid Arthritis | The Journal of Rheumatology Anticyclic Citrullinated Peptide Antibodies 3.1 and Anti-CCP-IgA Are Associated with Increasing Age in Individuals Without Rheumatoid Arthritis | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/46/12/1556/F1.large.jpg)
Anticyclic Citrullinated Peptide Antibodies 3.1 and Anti-CCP-IgA Are Associated with Increasing Age in Individuals Without Rheumatoid Arthritis | The Journal of Rheumatology
![The clinical value of anti-cyclic citrullinated peptide (anti-ccp) antibodies and insulin resistance (IR) in detection of early and subclinical atherosclerosis in rheumatoid arthritis (RA) - ScienceDirect The clinical value of anti-cyclic citrullinated peptide (anti-ccp) antibodies and insulin resistance (IR) in detection of early and subclinical atherosclerosis in rheumatoid arthritis (RA) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1110260815000022-gr2.jpg)
The clinical value of anti-cyclic citrullinated peptide (anti-ccp) antibodies and insulin resistance (IR) in detection of early and subclinical atherosclerosis in rheumatoid arthritis (RA) - ScienceDirect
![Comparison of the analytical and clinical performances of four anti-cyclic citrullinated peptide antibody assays for diagnosing rheumatoid arthritis | SpringerLink Comparison of the analytical and clinical performances of four anti-cyclic citrullinated peptide antibody assays for diagnosing rheumatoid arthritis | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10067-020-05412-w/MediaObjects/10067_2020_5412_Fig1_HTML.png)
Comparison of the analytical and clinical performances of four anti-cyclic citrullinated peptide antibody assays for diagnosing rheumatoid arthritis | SpringerLink
![Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement | Annals of the Rheumatic Diseases Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/63/10/1218/F1.large.jpg?download=true)
Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement | Annals of the Rheumatic Diseases
![SciELO - Brasil - Características laboratoriais de um grupo de pacientes com artrite reumatoide inicial Características laboratoriais de um grupo de pacientes com artrite reumatoide inicial SciELO - Brasil - Características laboratoriais de um grupo de pacientes com artrite reumatoide inicial Características laboratoriais de um grupo de pacientes com artrite reumatoide inicial](https://minio.scielo.br/documentstore/1809-4570/NSGJJPb55ywswDS9cDZX4Cg/4f9c642423d19fe4a3bff00f6fee890cf80b4d06.gif)